Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

Clicks: 451
ID: 120499
1993
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #36 of 183 articles by views in The New England journal of medicine

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 183 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Administration of high doses of respiratory syncytial virus immune globulin is a safe and effective means of preventing lower respiratory tract infection in infants and young children at high risk for this disease.
Reference Key
jr1993theprophylactic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Groothuis JR;Simoes EA;Levin MJ;Hall CB;Long CE;Rodriguez WJ;Arrobio J;Meissner HC;Fulton DR;Welliver RC;;
Journal The New England journal of medicine
Year 1993
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8413475
Keywords
immunization National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine logistic models research support non-u.s. gov't u.s. gov't female male Infant newborn P.H.S. risk factors Clinical Trial Randomized Controlled Trial Antibodies Multicenter Study immunoglobulins intravenous / therapeutic use* r c welliver respiratory syncytial virus infections / immunology respiratory syncytial virus infections / prevention & control* passive* respiratory syncytial viruses / immunology intravenous / administration & dosage heart defects opportunistic infections / prevention & control* viral / administration & dosage premature diseases / prevention & control* j r groothuis e a simoes bronchopulmonary dysplasia / complications congenital / complications diseases / immunology pmid:8413475 doi:10.1056/nejm199311183292102

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.